Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Accadis Hochschule Bad Homburg
InstitutionResearch output, impact & collaborations
Accadis Hochschule Bad Homburg is a research organisation in Bad Homburg, DE. OpenAlex records 1,362 works and 9,874 citations for it. 329 researchers list it as their most recent affiliation.
1,362
Works
9,874
Citations
329
Researchers
47
Avg h-index
How has Accadis Hochschule Bad Homburg's publication output changed over time?
ScholarIQpublication output · 2018–2025
Output declined50% over the shown period — from 2 works in 2018 to 1 in 2025.
2
2
2
3
1
1
201820202022202320242025
Who are the most-cited researchers behind Accadis Hochschule Bad Homburg?
ScholarIQtop researchers by citations
What are the most-cited papers on Accadis Hochschule Bad Homburg?
ScholarIQmost cited works
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
Ania M. Jastreboff, Lee M. Kaplan, Juan P. Frías, Qiwei Wu, Yu Du, Sirel Gurbuz, Tamer Coskun, Axel Haupt, Zvonko Miličević, Mark L. Hartman
New England Journal of Medicine. 20231,028 Citations
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
Rohit Loomba, Mark L. Hartman, Eric Lawitz, Raj Vuppalanchi, Jérôme Boursier, Elisabetta Bugianesi, Masato Yoneda, Cynthia Behling, Oscar W. Cummings, Yuanyuan Tang, Bram Brouwers, Deborah A. Robins, Amir Nikooie, Mathijs C. Bunck, Axel Haupt, Arun J. Sanyal
New England Journal of Medicine. 2024850 Citations
LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept
Tamer Coşkun, Kyle W. Sloop, Corina Loghin, Jorge Alsina‐Fernandez, Shweta Urva, Krister Bokvist, Xuewei Cui, Daniel A. Briere, Over Cabrera, William C. Roell, Uma Kuchibhotla, Julie S. Moyers, Charles Benson, Ruth E. Gimeno, David A. D’Alessio, Axel Haupt
S2764545133. 2018847 CitationsOPEN ACCESS
Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial
Juan P. Frías, Michael A. Nauck, Joanna Van, Mark E Kutner, Xuewei Cui, Charles Benson, Shweta Urva, Ruth E. Gimeno, Zvonko Miličević, Deborah A. Robins, Axel Haupt
The Lancet. 2018810 Citations
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
Sean Wharton, Thomas Blevins, Lisa Connery, Julio Rosenstock, Sohini Raha, Rong Liu, Xiaosu Ma, Kieren J. Mather, Axel Haupt, Deborah A. Robins, Edward Pratt, Christof Kazda, Маниге Кониг
New England Journal of Medicine. 2023431 Citations
How much of the research on Accadis Hochschule Bad Homburg is open access?
ScholarIQopen access share
55%OPEN ACCESS
Gold
9%
Green
9%
Hybrid
18%
Bronze
18%
Closed
45%